Clinical Trial

Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to investigate the relationship between central sensitization parameters and cognitive dysfunction in patients with fibromyalgia.The main questions it aims to answer are: Do central sensitization symptoms affect cognitive dysfunction in patients with fibromyalgia? To what extent do central sensitization symptoms affect objective and subjective cognitive complaints in fibromyalgia patients? How do cognitive complaints relate to other clinical parameters, including disease severity, in these patients?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-21.
Trial Details
NCT Number NCT06948903
Lead Sponsor Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Conditions Fibromyalgia, Cognitive Dysfunction, Central Sensitisation
Enrollment 100 participants
Start Date 2023-01-10
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12